Adherence and Persistence to Inclisiran Among Early Users in Germany

Clinical trial NCT05870657 · COMPLETED

Trial details

NCT number: NCT05870657
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

High Levels of Low-density Lipoprotein Cholesterol

Start date: 2022-02-16
Primary completion: 2022-05-12
Enrollment: 1109

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.